文献速递甲状腺与颈部外科围术期管理与 ERAS

锂相关原发性甲状旁腺功能亢进症:美国东南部退伍军人人群中筛查与转诊模式的评估

Lithium-associated primary hyperparathyroidism:: An evaluation of screening and referral patterns in a southeastern veteran population.
PubMed 文献 · Surgery · 2023-11-03

本研究评估1999至2022年接受长期锂治疗(>12个月)的美国退伍军人中高钙血症发生率、原发性甲状旁腺功能亢进症筛查及甲状旁腺切除术转诊情况。148例治疗后高钙血症患者中,112例(74.7%)未进一步评估,仅36例(25.3%)记录甲状旁腺激素水平;33例(91.7%)筛查阳性者中仅5例(13%)转诊手术。结论认为筛查和转诊利用不足,机构方案可能使该高危人群获益。

要点

  • 长期锂治疗退伍军人中,高钙血症患者多数未进一步评估原发性甲状旁腺功能亢进症。
  • 筛查阳性的高钙血症患者中仅少数被转诊至甲状旁腺切除术。
  • 作者认为机构方案标准化筛查、监测和转诊可能使该高危人群获益。

核心结论

  • 在接受长期锂治疗的美国退伍军人中,原发性甲状旁腺功能亢进症的筛查和甲状旁腺切除术转诊利用不足。
  • 作者认为,制定机构方案以标准化筛查、监测和转诊至内分泌科/内分泌外科可能使这一原发性甲状旁腺功能亢进症风险增加的人群获益。

研究设计与样本

  • 研究纳入1999年至2022年接受慢性长期锂治疗(>12个月)的患者,共1356例接受长期锂治疗,其中514例接受慢性长期锂治疗。
  • 提取人口学资料、长期锂治疗时长、治疗后钙、甲状旁腺激素、肌酐和维生素D水平。
  • 评估高钙血症(钙≥10.2 mg/dL)筛查率、原发性甲状旁腺功能亢进症(高钙血症背景下甲状旁腺激素≥30 pg/mL)筛查率、甲状旁腺切除术转诊率及结局。

主要发现

  • 148例患者出现治疗后高钙血症,其中112例(74.7%)未进一步评估原发性甲状旁腺功能亢进症,36例(25.3%)记录了甲状旁腺激素水平。
  • 33例(91.7%)高钙血症患者筛查原发性甲状旁腺功能亢进症阳性,但仅5例(13%)被转诊行甲状旁腺切除术。
  • 4例接受甲状旁腺切除术的患者中,平均钙为11.2 mg/dL(范围11.1-11.4),平均甲状旁腺激素为272 pg/mL(范围108-622)。
  • 4例手术患者中,3例术前影像定位,其中2例行单侧探查治愈,1例在31个月时复发;另1例术前定位者行双侧探查,切除2枚同侧腺体后持续存在;1例术前未定位者行双侧探查,切除3枚腺体后治愈。

关键数值与推荐

  • 高钙血症定义为钙≥10.2 mg/dL。
  • 原发性甲状旁腺功能亢进症筛查阳性定义为高钙血症背景下甲状旁腺激素≥30 pg/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term lithium therapy has a well-established but under-recognized association with primary hyperparathyroidism. Rates of hypercalcemia, screening for primary hyperparathyroidism, and referral for parathyroidectomy were evaluated among United States veterans on long-term lithium therapy. METHODS: Patients undergoing chronic long-term lithium therapy (>12 months) were identified from 1999 to 2022. Demographics, long-term lithium therapy duration, post-treatment calcium, parathyroid hormone, creatinine, and vitamin D levels were abstracted. Rates of screening for hypercalcemia (calcium ≥10.2 mg/dL), primary hyperparathyroidism (parathyroid hormone ≥30 pg/mL in the setting of hypercalcemia), referral for parathyroidectomy, and outcomes were evaluated. RESULTS: A total of 1,356 patients underwent long-term lithium therapy, 514 of whom received chronic long-term lithium therapy. Baseline characteristics of patients with and without post-treatment hypercalcemia were compared. Of 148 patients with post-treatment hypercalcemia, 112 (74.7%) underwent no further evaluation for primary hyperparathyroidism, while 36 (25.3%) patients had a parathyroid hormone level recorded. Although 33 (91.7%) hypercalcemic patients screened positive for primary hyperparathyroidism, only 5 (13%) were referred for parathyroidectomy. Of the 4 patients who underwent parathyroidectomy, mean calcium was 11.2 mg/dL (range 11.1-11.4), and mean parathyroid hormone was 272 pg/mL (range 108-622). Three patients were localized on preoperative imaging, 2 of whom underwent unilateral exploration with cure, with 1 experiencing recurrence at 31 months. The remaining patient who localized preoperatively underwent bilateral exploration and had 2 ipsilateral glands resected and persistence. The patient who did not localize preoperatively underwent bilateral exploration with 3 gland resection and cure. CONCLUSIONS: Screening for primary hyperparathyroidism and referral for parathyroidectomy are underutilized in United States veterans undergoing chronic long-term lithium therapy. Institutional protocols to standardize screening, surveillance, and referrals to endocrinology/endocrine surgery could benefit this population at increased risk for primary hyperparathyroidism.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Hendrick LE, Fleming AM, Sullivan JW, et al. Lithium-associated primary hyperparathyroidism:: An evaluation of screening and referral patterns in a southeastern veteran population. Surgery. 2023. PMID: 37925259. doi:10.1016/j.surg.2023.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。